Related references
Note: Only part of the references are listed.Raftlin Is Involved in the Nucleocapture Complex to Induce Poly(I:C)-mediated TLR3 Activation
Ayako Watanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
TLR3-Specific Double-Stranded RNA Oligonucleotide Adjuvants Induce Dendritic Cell Cross-Presentation, CTL Responses, and Antiviral Protection
Ivett Jelinek et al.
JOURNAL OF IMMUNOLOGY (2011)
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
Thomas Krausgruber et al.
NATURE IMMUNOLOGY (2011)
Antiviral responses induced by the TLR3 pathway
Misako Matsumoto et al.
REVIEWS IN MEDICAL VIROLOGY (2011)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation
Takashi Ebihara et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Subhra K. Biswas et al.
NATURE IMMUNOLOGY (2010)
The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection
Takashi Satoh et al.
NATURE IMMUNOLOGY (2010)
Regulation of Adaptive Immunity by the Innate Immune System
Akiko Iwasaki et al.
SCIENCE (2010)
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Fernando O. Martinez et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer
Tsukasa Seya et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells
Stephen McCartney et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
M. Paula Longhi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Poly I:C-Induced Activation of NK Cells by CD8α+ Dendritic Cells via the IPS-1 and TRIF-Dependent Pathways
Tohru Miyake et al.
JOURNAL OF IMMUNOLOGY (2009)
TLR3:: Interferon induction by double-stranded RNA including poly(I:C)
Misako Matsumoto et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Inflammation and cancer: The oncogene-driven connection
Maria Grazia Borrello et al.
CANCER LETTERS (2008)
The Innate Immune Receptor Nod1 Protects the Intestine from Inflammation-induced Tumorigenesis
Grace Y. Chen et al.
CANCER RESEARCH (2008)
The role of myeloid cells in the promotion of tumour angiogenesis
Craig Murdoch et al.
NATURE REVIEWS CANCER (2008)
The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing
Francesca De Santa et al.
CELL (2007)
Tumor immunotherapy using bone marrow-derived dendritic cells overexpressing Toll-like receptor adaptors
Takashi Akazawa et al.
FEBS LETTERS (2007)
Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88
Seth Rakoff-Nahoum et al.
SCIENCE (2007)
The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4
Veronica Mata-Haro et al.
SCIENCE (2007)
Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factor
Jeffrey M. Farma et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2
Andrew T. Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells
Takashi Akazawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type IIFN induction
Miwa Sasai et al.
JOURNAL OF IMMUNOLOGY (2006)
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation)
SK Biswas et al.
BLOOD (2006)
Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis
J Condeelis et al.
CELL (2006)
Paradoxical roles of the immune system during cancer development
KE de Visser et al.
NATURE REVIEWS CANCER (2006)
Oncolytic viral therapies - the clinical experience
M Aghi et al.
ONCOGENE (2005)
Diminished expression of transcription factors nuclear factor κB and CCAAT/enhancer binding protein underlies a novel tumor evasion mechanism affecting macrophages of mammary tumor-bearing mice.
M Torroella-Kouri et al.
CANCER RESEARCH (2005)
Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity
M Yoneyama et al.
JOURNAL OF IMMUNOLOGY (2005)
Toll-like receptor 3 promotes cross-priming to virus-infected cells
O Schulz et al.
NATURE (2005)
Tumor necrosis factor, cancer and anticancer therapy
S Mocellin et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Adjuvant-mediated tumor regression and tumor-specific cytotoxic response are impaired in MyD88-deficient mice
T Akazawa et al.
CANCER RESEARCH (2004)
The chemokine system in diverse forms of macrophage activation and polarization
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2004)
NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
The use of dendritic cells in cancer immunotherapy
G Schuler et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction
H Oshiumi et al.
NATURE IMMUNOLOGY (2003)
RNA viruses as virotherapy agents
SJ Russell
CANCER GENE THERAPY (2002)
High levels of RAE-1 isoforms on mouse tumor cell lines assessed by anti-pan RAE-1 antibody confer tumor susceptibility to NK cells
H Masuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Regulation of the CTL response by macrophage migration inhibitory factor
R Abe et al.
JOURNAL OF IMMUNOLOGY (2001)
Autocrine production of IL-10 mediates defective IL-12 production and NF-κB activation in tumor-associated macrophages
A Sica et al.
JOURNAL OF IMMUNOLOGY (2000)